{
  "meta": {
    "timestamp": "2025-01-06T12:44:29.938237",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Irhythm Technologies Inc",
      "symbol": "IRTC",
      "analysis": {
        "historical": {
          "risk_score": 65,
          "key_risks": [
            "Reimbursement volatility and uncertainty, particularly with Medicare",
            "Regulatory scrutiny and legal risks, including FDA warning letters and securities fraud lawsuits",
            "Intense competition in the cardiac monitoring market",
            "Heavy reliance on the U.S. market, making the company vulnerable to domestic economic and regulatory changes",
            "Data privacy and security concerns related to cloud-based health data solutions"
          ],
          "controversies": [
            "FDA warning letter in 2022 regarding manufacturing issues and delays in reporting adverse events, including two patient deaths",
            "Securities fraud class action lawsuit alleging misrepresentation of the Zio AT monitor's capabilities"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Data privacy and security concerns for patient information"
          ],
          "governance_issues": [
            "Recent leadership changes, including the appointment of a new CEO, to navigate reimbursement challenges and drive growth"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "Reimbursement Woes Continue for iRhythm Technologies - MDDI Online",
              "snippet": "iRhythm Technologies' stock took another nosedive Monday after Medicare Administrative Contractor (MAC) Novitas Solutions updated its reimbursement rates over the weekend for codes that cover iRhythm's Zio Patch.The new rates for CPT codes (current procedural terminology) 93243 and 93247 were set at $103 and $115, respectively, and are retroactive to the beginning of the year.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc CMS reimbursement rate cuts impact",
              "retrieved_at": "2025-01-06T19:44:02.656066+00:00",
              "published_date": null,
              "source_hash": "8b240473e683329f5b3f4f9ac13d4bc2"
            },
            {
              "url": "",
              "title": "The Reimbursement Tide May Be Turning for iRhythm",
              "snippet": "After initially slashing reimbursement rates for for CPT (current procedural terminology) codes that cover iRhythm Technologies' Zio Patch to about $43 from about $300 nearly a year ago, Novitas upped the rates in April to $103 and $115. iRhythm said at that time it would discontinue providing its Zio XT service (Zio Patch) to the Medicare fee ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc CMS reimbursement rate cuts impact",
              "retrieved_at": "2025-01-06T19:44:02.656175+00:00",
              "published_date": null,
              "source_hash": "0937d3f2ad46328bdcf0c6698bd7e09f"
            },
            {
              "url": "",
              "title": "iRhythm Technologies, Inc. - iRhythm\u00ae Technologies Comments on the ...",
              "snippet": "SAN FRANCISCO, July 08, 2022 (GLOBE NEWSWIRE) - iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today provided comment on the recently released Centers for Medicare and Medicaid Services (CMS) Medicare Physician Fee Schedule Proposed Rule for Calendar Year 2023 (the Proposed Rule). The Proposed Rule was ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc CMS reimbursement rate cuts impact",
              "retrieved_at": "2025-01-06T19:44:02.656190+00:00",
              "published_date": null,
              "source_hash": "62a08f900c182f4bacfed8254f106ddb"
            },
            {
              "url": "",
              "title": "iRhythm\u00ae Technologies Comments on the Final Medicare Physician Fee ...",
              "snippet": "Using the Final Rule's implied rates and based on the Company's current expectations for volume mix in calendar year 2023 across its IDTF locations, iRhythm estimates that, if the calendar ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc CMS reimbursement rate cuts impact",
              "retrieved_at": "2025-01-06T19:44:02.656206+00:00",
              "published_date": null,
              "source_hash": "333223bca1f0de1483adf861e0c20f31"
            },
            {
              "url": "",
              "title": "iRhythm scores an important reimbursement win",
              "snippet": "iRhythm Technologies (NSDQ:IRTC) and other companies pioneering remote external EKG monitoring have scored a significant reimbursement win. The regional Medicare administrative contractor Novitas Solutions has set CPT codes 93243 and 93247 at roughly $223 and $233 respectively \u2014 news first reported by analysts this morning.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc CMS reimbursement rate cuts impact",
              "retrieved_at": "2025-01-06T19:44:02.656217+00:00",
              "published_date": null,
              "source_hash": "f6a73addaea3feb2e6989e8dc7fe500a"
            },
            {
              "url": "",
              "title": "iRhythm\u00ae Technologies Comments on the Centers for Medicare and Medicaid ...",
              "snippet": "SAN FRANCISCO, July 14, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today provided comment on the recently released Centers for Medicare and Medicaid Services (\"CMS\") Calendar Year 2022 Medicare Physician Fee Schedule Proposed Rule (the \"Proposed Rule\").",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc CMS reimbursement rate cuts impact",
              "retrieved_at": "2025-01-06T19:44:02.656231+00:00",
              "published_date": null,
              "source_hash": "901811d378330a9ed371b877c3f092c1"
            },
            {
              "url": "",
              "title": "iRhythm\u00ae Technologies Comments on the Announcement of the Medicare ...",
              "snippet": "The SD339 supply item price of $260.35 in the Final Rule is a positive improvement from the $245.69 price that CMS included in their Proposed Rule issued in July 2022. iRhythm is waiting for the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc CMS reimbursement rate cuts impact",
              "retrieved_at": "2025-01-06T19:44:02.656242+00:00",
              "published_date": null,
              "source_hash": "6f772a25fed8e7f3f027a38beaeac6bf"
            },
            {
              "url": "",
              "title": "iRhythm stock jumps nearly 28% after Novitas doubles Medicare rates for ...",
              "snippet": "Novitas cut Medicare rates for extended external monitoring to a range between $40 to $50 in January 2021 after CMS passed on setting a national price for the devices and services in December 2020. The MAC eventually upped the reimbursement rate for iRhythm's primary code to $115 in April, but this was still nearly $200 below historic pricing.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc CMS reimbursement rate cuts impact",
              "retrieved_at": "2025-01-06T19:44:02.656253+00:00",
              "published_date": null,
              "source_hash": "253dd0c4534e38144a50d4789c8d955c"
            },
            {
              "url": "",
              "title": "iRhythm Technologies Comments on Medicare Administrative Contractor ...",
              "snippet": "SAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, commented on ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc CMS reimbursement rate cuts impact",
              "retrieved_at": "2025-01-06T19:44:02.656267+00:00",
              "published_date": null,
              "source_hash": "07824b00edfc553655f5ed7e19f0f53f"
            },
            {
              "url": "",
              "title": "Updated: iRhythm Continues To Grow Despite Reimbursement, Hospital ...",
              "snippet": "Updated: iRhythm Continues To Grow Despite Reimbursement, Hospital-Staffing Challenges CMS' Decision To Punt Remote Monitoring Payment To 2023 Disappoints iRhythm Again 05 Nov 2021",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc CMS reimbursement rate cuts impact",
              "retrieved_at": "2025-01-06T19:44:02.656279+00:00",
              "published_date": null,
              "source_hash": "3aec00044ab8d77a6fbc236b223d6a4f"
            },
            {
              "url": "",
              "title": "iRhythm Technologies, Inc. (IRTC)",
              "snippet": "SAN FRANCISCO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ ... and the potential health care resource and economic impact of early arrhythmia detection in patients with ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc CMS reimbursement rate cuts impact",
              "retrieved_at": "2025-01-06T19:44:05.923238+00:00",
              "published_date": "2025-01-03T22:13:00+00:00",
              "source_hash": "6d326ca0345d8d58ccfd604bde3ad700"
            },
            {
              "url": "",
              "title": "iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference",
              "snippet": "SAN FRANCISCO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc CMS reimbursement rate cuts impact",
              "retrieved_at": "2025-01-06T19:44:05.923364+00:00",
              "published_date": "2024-11-20T21:30:00+00:00",
              "source_hash": "08224d3395114fc072c26fdc0ad1bd74"
            },
            {
              "url": "",
              "title": "Notice to Long-Term iRhythm Technologies, Inc. (IRTC) Shareholders ...",
              "snippet": "WHY: A recently filed securities fraud class action complaint alleges that iRhythm Technologies, via certain of its officers and directors, falsely represented to investors that the Zio AT monitor ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc data privacy breaches",
              "retrieved_at": "2025-01-06T19:44:07.378316+00:00",
              "published_date": null,
              "source_hash": "277a846d855e4f4e283c5e10468c605f"
            },
            {
              "url": "",
              "title": "Kaskela Law LLC Announces Shareholder Investigation of iRhythm ...",
              "snippet": "Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the Firm Provided by GlobeNewswire Sep 20 ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc data privacy breaches",
              "retrieved_at": "2025-01-06T19:44:07.378376+00:00",
              "published_date": null,
              "source_hash": "2a851015abc1abda53120c5f6259b734"
            },
            {
              "url": "",
              "title": "2025-01-05 | Bronstein, Gewirtz & Grossman, LLC Announces an ...",
              "snippet": "NEW YORK CITY, NY / ACCESSWIRE / January 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. (\"iRhythm\" or \"the Company\") (NASDAQ:IRTC).Investors who purchased iRhythm securities prior to January 11, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc data privacy breaches",
              "retrieved_at": "2025-01-06T19:44:07.378387+00:00",
              "published_date": null,
              "source_hash": "d1bec00363f75e84624cf3b3fc5a8766"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of ...",
              "snippet": "/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of iRhythm Technologies, Inc. (\"iRhythm\" or the \"Company\") (NASDAQ: IRTC). Such...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc data privacy breaches",
              "retrieved_at": "2025-01-06T19:44:07.378397+00:00",
              "published_date": null,
              "source_hash": "40ce6acaa1c5d7fd6e594139e54a7494"
            },
            {
              "url": "",
              "title": "Irhythm Investigation Initiated by Former Louisiana Attorney General ...",
              "snippet": "If you have information that would assist KSF in its investigation, or have been a long-term holder of iRhythm shares and would like to discuss your legal rights, you may, without obligation or ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc data privacy breaches",
              "retrieved_at": "2025-01-06T19:44:07.378406+00:00",
              "published_date": null,
              "source_hash": "7cef96da793e345b33fc9ea392e0eb7d"
            },
            {
              "url": "",
              "title": "iRhythm Technologies, Inc. - 643474 - 05/25/2023 | FDA",
              "snippet": "WARNING LETTER CMS# 643474. May 25, 2023 iRhythm Technologies, Inc. 6550 Katella Ave Cypress, CA 90630. Dear Mr. Blackford, During an inspection of your firm located at 6550 Katella Ave in Cypress ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc data privacy breaches",
              "retrieved_at": "2025-01-06T19:44:07.378413+00:00",
              "published_date": null,
              "source_hash": "0f2cb9871cc59593619bd4bdcb4c3355"
            },
            {
              "url": "",
              "title": "iRhythm | Bernstein Litowitz Berger & Grossmann LLP",
              "snippet": "On February 6, 2024, Bernstein Litowitz Berger & Grossmann LLP (\"BLB&G\") filed a class action lawsuit in the U.S. District Court for the Northern District of California alleging violations of the federal securities laws by iRhythm Technologies, Inc. (\"iRhythm\" or the \"Company\") and certain of the Company's current and former senior executives (collectively, \"Defendants\").",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc data privacy breaches",
              "retrieved_at": "2025-01-06T19:44:07.378420+00:00",
              "published_date": null,
              "source_hash": "bbc01a9b66bfbacf3aab60d4b9d7923d"
            },
            {
              "url": "",
              "title": "iRhythm Technologies - Kaskela Law",
              "snippet": "Kaskela Law LLC is investigating iRhythm Technologies, Inc. (NASDAQ: IRTC) (\"iRhythm\") on behalf of the company's long-term shareholders. Recently a securities fraud complaint was filed against iRhythm on behalf of investors who purchased shares of the company's stock between November 5, 2021 and May 30, 2023 (the \"Class Period\"). According to the complaint, during the [\u2026]",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc data privacy breaches",
              "retrieved_at": "2025-01-06T19:44:07.378429+00:00",
              "published_date": null,
              "source_hash": "2b1c401603a50089157e389f3342dbd0"
            },
            {
              "url": "",
              "title": "IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm ...",
              "snippet": "NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against iRhythm Technologies, Inc ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc data privacy breaches",
              "retrieved_at": "2025-01-06T19:44:07.378441+00:00",
              "published_date": null,
              "source_hash": "5a07f68e0f58655e11eb903439e1ecf1"
            },
            {
              "url": "",
              "title": "United States of America v. iRhythm Technologies, Inc.",
              "snippet": "iRhythm Technologies, Inc. Case Number: 3:2024cv03967: Filed: July 1, 2024: Court: US District Court for the Northern District of California: Presiding Judge: Araceli Martinez-Olguin: Nature of Suit: Other Statutory Actions: Cause of Action: 49 U.S.C. \u00a7 1903 Petition to enforce administrative summons: Jury Demanded By: None",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc data privacy breaches",
              "retrieved_at": "2025-01-06T19:44:07.378448+00:00",
              "published_date": null,
              "source_hash": "0c7473e1d1fce65156d4a0b9b46199ed"
            },
            {
              "url": "",
              "title": "iRhythm Technologies, Inc. (IRTC)",
              "snippet": "SAN FRANCISCO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:14.053607+00:00",
              "published_date": "2025-01-03T22:13:00+00:00",
              "source_hash": "8abc80e93292b4a31686e8ca7ecfccff"
            },
            {
              "url": "",
              "title": "iRhythm Technologies Stock Rises Post FDA Clearance for Zio AT",
              "snippet": "iRhythm Technologies, Inc. IRTC has received FDA 510(k ... It includes the Zio AT patch, which records ECG data for up to 14 days, and a wireless gateway that transmits data to iRhythm's Zio ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc data privacy breaches",
              "retrieved_at": "2025-01-06T19:44:09.898752+00:00",
              "published_date": "2024-10-22T16:43:00+00:00",
              "source_hash": "691a42af4166ad3db9f9ab11fb1ad9bb"
            },
            {
              "url": "",
              "title": "iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference",
              "snippet": "SAN FRANCISCO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ ... more about how we handle and protect your data, visit our privacy center. Maintaining independence and ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc data privacy breaches",
              "retrieved_at": "2025-01-06T19:44:09.898783+00:00",
              "published_date": "2024-12-30T13:30:00+00:00",
              "source_hash": "ac0bb8e3ebe64060f8ae90b84ac9c2d0"
            },
            {
              "url": "",
              "title": "iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference",
              "snippet": "SAN FRANCISCO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ ... Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc data privacy breaches",
              "retrieved_at": "2025-01-06T19:44:09.898808+00:00",
              "published_date": "2024-11-05T21:30:00+00:00",
              "source_hash": "b365c5032d0f48f39bf114f6c573d7f5"
            },
            {
              "url": "",
              "title": "iRhythm Technologies (NASDAQ:IRTC) Stock, Insider Trading Activity",
              "snippet": "At iRhythm Technologies Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 2.49K shares worth $214.04K, meanwhile, insiders have ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc data privacy breaches",
              "retrieved_at": "2025-01-06T19:44:09.898831+00:00",
              "published_date": "2023-05-12T15:34:00+00:00",
              "source_hash": "3eb7c04b8f8bc978dc4ab4756bb77802"
            },
            {
              "url": "",
              "title": "FDA clears iRhythm's second 510(k) in response to warning letter",
              "snippet": "Dive Brief: The Food and Drug Administration gave 510(k) clearance to iRhythm Technologies' second of two submissions for its Zio AT wearable cardiac monitoring system, moving the company a step closer to resolving a warning letter over problems found at a manufacturing facility. The clearance covers design modifications and labeling updates. The update, shared Wednesday during iRhythm's ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:11.702920+00:00",
              "published_date": null,
              "source_hash": "105b4bf5b86a525b22a49b6892423b6e"
            },
            {
              "url": "",
              "title": "iRhythm secures 510(k) clearance for Zio device updates after FDA ...",
              "snippet": "iRhythm Technologies Inc View all. ... and delays in reporting adverse events, particularly relating to two patient deaths while using the device. iRhythm confirmed receipt via a Form 8-K. ... The system secured Japanese regulatory approval last month. Shares in iRhythm are up by 17.9% following the clearance, increasing from \u20ac56 ($60.6) at ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:11.703023+00:00",
              "published_date": null,
              "source_hash": "591fd12dcab44aa2b7a731e4fe176f6a"
            },
            {
              "url": "",
              "title": "With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang ...",
              "snippet": "On Monday, the FDA approved iRhythm Technologies, Inc.'s (NASDAQ:IRTC) 510(k) submission related to prior design changes to the Zio AT device via letter to file. Zio AT remains commercially ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:11.703041+00:00",
              "published_date": null,
              "source_hash": "e05821e6e126026629daafedf34bb859"
            },
            {
              "url": "",
              "title": "FDA clears second set of changes to iRhythm Zio AT",
              "snippet": "The iRhythm Zio AT [Image courtesy of iRhythm] iRhythm Technologies (Nasdaq:IRTC) announced that the FDA granted 510(k) clearance for Zio AT design modifications and labeling updates.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:11.703052+00:00",
              "published_date": null,
              "source_hash": "57badb324276c94685a8f4df51785eef"
            },
            {
              "url": "",
              "title": "iRhythm shares soar after FDA clears Zio AT device updates - Yahoo Finance",
              "snippet": "Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) surged 10.6% in pre-market trading on Tuesday after the company said that it had secured U.S. Food and Drug Administration clearance for updates ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:11.703061+00:00",
              "published_date": null,
              "source_hash": "b89f2f9fb5b0a3ce00869693019c344a"
            },
            {
              "url": "",
              "title": "iRhythm Technologies, Inc. - iRhythm Technologies Receives FDA 510 (k ...",
              "snippet": "Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients FDA 510(k)-cleared enhancements will be available in 2025 SAN FRANCISCO, Oct. 30, 2024 (GLOBE NEWSWIRE) - iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:11.703072+00:00",
              "published_date": null,
              "source_hash": "fbc6e2103585e57b2761283a1aaa057f"
            },
            {
              "url": "",
              "title": "iRhythm Technologies Receives FDA 510(k) Clearance for ... - Morningstar",
              "snippet": "Zio AT Clinical Reference Manual. iRhythm Technologies, 2022. Data on file. iRhythm Technologies, 2021-2022. Based on a review of all online Zio XT, Zio monitor, and Zio AT end-of-wear reports ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:11.703081+00:00",
              "published_date": null,
              "source_hash": "19dea2befa4487c6488bda44f89b134d"
            },
            {
              "url": "",
              "title": "iRhythm Technologies Receives FDA 510(k) Clearance for Design ...",
              "snippet": "Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:11.703090+00:00",
              "published_date": null,
              "source_hash": "1615042b53af4099ffcc8bb116adf243"
            },
            {
              "url": "",
              "title": "iRhythm IRTC Stock Soars 16% on FDA Clearance for Cardiac Monitoring ...",
              "snippet": "iRhythm Technologies, Inc. (IRTC) The regulatory approval comes at a crucial time for iRhythm, which has been working to resolve issues raised in an FDA warning letter from May 2024. The warning letter, issued after an inspection of the company's Cypress, California facility, cited violations of the Federal Food, Drug, and Cosmetic Act ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:11.703098+00:00",
              "published_date": null,
              "source_hash": "a3c0c825d6e478e30875f6d1359ee87d"
            },
            {
              "url": "",
              "title": "iRhythm Technologies Receives FDA 510(k) Clearance for Zio AT Device ...",
              "snippet": "iRhythm Technologies, Inc., a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for its 510(k) submission related to prior design changes made to the Zio AT device via letter to file.Zio AT remains commercially available on the market to ship ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:11.703108+00:00",
              "published_date": null,
              "source_hash": "3e13f03c236e4e8941cf2033d89c6469"
            },
            {
              "url": "",
              "title": "iRhythm's Zio ECG monitoring system secures Japanese regulatory approval",
              "snippet": "The Japanese Pharmaceutical and Medical Device Agency (PMDA) has approved iRhythm Technologies' Zio ... monitoring system secures Japanese regulatory approval\" was originally created and ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:14.053473+00:00",
              "published_date": "2024-09-12T16:34:00+00:00",
              "source_hash": "98a8171d3d9adfc1cd684b2359b73419"
            },
            {
              "url": "",
              "title": "iRhythm Technologies Stock Rises Post FDA Clearance for Zio AT",
              "snippet": "iRhythm Technologies, Inc. IRTC has received FDA 510(k ... Last month, iRhythm Technologies gained regulatory approval from Japan's PMDA for its Zio 14-day, long-term continuous ECG monitoring ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:14.053576+00:00",
              "published_date": "2024-10-22T16:43:00+00:00",
              "source_hash": "d1a4e86d06d084a204b6ee9066ce436e"
            },
            {
              "url": "",
              "title": "iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference",
              "snippet": "SAN FRANCISCO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:14.053631+00:00",
              "published_date": "2024-12-30T22:30:00+00:00",
              "source_hash": "36a6d688b8b33911f1d31f20899f1626"
            },
            {
              "url": "",
              "title": "iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference",
              "snippet": "SAN FRANCISCO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Irhythm Technologies Inc Irhythm Technologies Inc regulatory approval delays",
              "retrieved_at": "2025-01-06T19:44:14.053653+00:00",
              "published_date": "2024-11-05T21:30:00+00:00",
              "source_hash": "edb35a78b65bbc4397e8a4f9e0ff846d"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Irhythm Technologies Inc CMS reimbursement rate cuts impact",
              "rationale": "Investigate the financial and legal implications of CMS reimbursement rate cuts on iRhythm's revenue and operations",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "Irhythm Technologies Inc data privacy breaches",
              "rationale": "Assess any known incidents or concerns related to patient data privacy and security in iRhythm's cloud-based platforms",
              "priority": 2
            },
            {
              "category": "financial_legal",
              "query": "Irhythm Technologies Inc regulatory approval delays",
              "rationale": "Examine potential delays or issues in obtaining regulatory approvals for iRhythm's products in international markets",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T12:44:29.938245",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}